Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 047
mi
from
Chino, CA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 047
mi
from
Chino, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative site 049
mi
from
Los Angeles, CA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative site 049
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site #025
mi
from
Newport Beach, CA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site #025
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site
mi
from
Cromwell, CT
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site
mi
from
Cromwell, CT
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 1775
mi
from
Doral, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 1775
mi
from
Doral, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site #015
mi
from
Fort Myers, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 055
mi
from
Hallandale Beach, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 055
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 061
mi
from
Orlando, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 032
mi
from
West Palm Beach, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 032
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 059
mi
from
Winter Park, FL
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 059
mi
from
Winter Park, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site
mi
from
Indianapolis, IN
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 025
mi
from
New York, NY
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 004
mi
from
Durham, NC
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 004
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site
mi
from
Oklahoma City, OK
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 1826
mi
from
Plano, TX
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 1826
mi
from
Plano, TX
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 062
mi
from
San Antonio, TX
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 062
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 020
mi
from
Richmond, VA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 020
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  5/15/2015
Forest Investigative Site 103
mi
from
Pleven,
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 5/15/2015
Forest Investigative Site 103
mi
from
Pleven,
Click here to add this to my saved trials
Low-Dose Naltrexone for Depression Relapse and Recurrence
Randomized, Proof-Of-Concept Trial of Augmentation of Anti-depressants by Low Dose and Ultra-Low Dose Naltrexone for Patients With Breakthrough Symptoms of Major Depressive Disorder on Antidepressant Therapy
Status: Enrolling
Updated:  7/1/2015
Massachusetts General Hospital; Depression Research and Clinical Program
mi
from
Boston, MA
Low-Dose Naltrexone for Depression Relapse and Recurrence
Randomized, Proof-Of-Concept Trial of Augmentation of Anti-depressants by Low Dose and Ultra-Low Dose Naltrexone for Patients With Breakthrough Symptoms of Major Depressive Disorder on Antidepressant Therapy
Status: Enrolling
Updated: 7/1/2015
Massachusetts General Hospital; Depression Research and Clinical Program
mi
from
Boston, MA
Click here to add this to my saved trials
Pioglitazone and Quetiapine XR Pharmacogenetic Study
Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
Status: Enrolling
Updated:  7/8/2015
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Pioglitazone and Quetiapine XR Pharmacogenetic Study
Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
Status: Enrolling
Updated: 7/8/2015
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Expert System to Reduce Depression in Primary Care
An Expert System to Reduce Depression in Primary Care
Status: Enrolling
Updated:  7/10/2015
John H. Stroger Hospital
mi
from
Chicago, IL
An Expert System to Reduce Depression in Primary Care
An Expert System to Reduce Depression in Primary Care
Status: Enrolling
Updated: 7/10/2015
John H. Stroger Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
An Expert System to Reduce Depression in Primary Care
An Expert System to Reduce Depression in Primary Care
Status: Enrolling
Updated:  7/10/2015
Harvard Vanguard Medical Associates
mi
from
Newton, MA
An Expert System to Reduce Depression in Primary Care
An Expert System to Reduce Depression in Primary Care
Status: Enrolling
Updated: 7/10/2015
Harvard Vanguard Medical Associates
mi
from
Newton, MA
Click here to add this to my saved trials
Depression, Epinephrine, and Platelet Function
Do Antidepressants Reverse the Effects of Early Life Stress on the Brain and Thrombovascular System and Improve Psychological, Neuroendocrine, and Platelet Function: A Study of Men and Women With Childhood Abuse.
Status: Enrolling
Updated:  7/15/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Depression, Epinephrine, and Platelet Function
Do Antidepressants Reverse the Effects of Early Life Stress on the Brain and Thrombovascular System and Improve Psychological, Neuroendocrine, and Platelet Function: A Study of Men and Women With Childhood Abuse.
Status: Enrolling
Updated: 7/15/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder
Translating Affective Science to Predict Outcomes of Behavioral Treatment for MDD
Status: Enrolling
Updated:  7/20/2015
Northwestern University Stress and Depression Laboratory
mi
from
Chicago, IL
Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder
Translating Affective Science to Predict Outcomes of Behavioral Treatment for MDD
Status: Enrolling
Updated: 7/20/2015
Northwestern University Stress and Depression Laboratory
mi
from
Chicago, IL
Click here to add this to my saved trials
Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Chicago Urban Resiliency Building (CURB)
Chicago Urban Resiliency Building (CURB): Phase 3 Clinical Trial in Primary Care to Engage Adolescents With a Web-based Depression Prevention Intervention
Status: Enrolling
Updated:  7/31/2015
Mile Square Health Centers
mi
from
Chicago, IL
Chicago Urban Resiliency Building (CURB)
Chicago Urban Resiliency Building (CURB): Phase 3 Clinical Trial in Primary Care to Engage Adolescents With a Web-based Depression Prevention Intervention
Status: Enrolling
Updated: 7/31/2015
Mile Square Health Centers
mi
from
Chicago, IL
Click here to add this to my saved trials
Whole Body Hyperthermia and Major Depression (MDD)
Whole Body Hyperthermia and Major Depression (MDD)
Status: Enrolling
Updated:  8/6/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia and Major Depression (MDD)
Whole Body Hyperthermia and Major Depression (MDD)
Status: Enrolling
Updated: 8/6/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Brain on Whole Body Hyperthermia: A Neuroimaging Study
The Brain on Whole Body Hyperthermia: A Neuroimaging Study
Status: Enrolling
Updated:  8/6/2015
University of Arizona
mi
from
Tucson, AZ
The Brain on Whole Body Hyperthermia: A Neuroimaging Study
The Brain on Whole Body Hyperthermia: A Neuroimaging Study
Status: Enrolling
Updated: 8/6/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Georgia Health Sciences University
mi
from
Augusta, GA
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Carolina Behavioral Care
mi
from
Durham, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Carolina Behavioral Care
mi
from
Durham, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
North Carolina Psychiatric Research Center
mi
from
Raleigh, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
North Carolina Psychiatric Research Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Interpersonal Therapy for Depression in Breast Cancer
Interpersonal Therapy for Depression in Breast Cancer
Status: Enrolling
Updated:  9/8/2015
New York State Psychiatric Institute
mi
from
New York, NY
Interpersonal Therapy for Depression in Breast Cancer
Interpersonal Therapy for Depression in Breast Cancer
Status: Enrolling
Updated: 9/8/2015
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Improving Depression Outcome by Enhancing Memory for Cognitive Therapy
Improving Depression Outcome by Enhancing Memory for Cognitive Therapy
Status: Enrolling
Updated:  9/16/2015
University of California, Berkeley
mi
from
Berkeley, CA
Improving Depression Outcome by Enhancing Memory for Cognitive Therapy
Improving Depression Outcome by Enhancing Memory for Cognitive Therapy
Status: Enrolling
Updated: 9/16/2015
University of California, Berkeley
mi
from
Berkeley, CA
Click here to add this to my saved trials
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive, Flexibly-Dosed Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment In Major Depressive Disorder (MDD) Partially Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Monotherapy
Status: Enrolling
Updated:  9/21/2015
McLean Hospital
mi
from
Belmont, MA
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive, Flexibly-Dosed Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment In Major Depressive Disorder (MDD) Partially Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Monotherapy
Status: Enrolling
Updated: 9/21/2015
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
Status: Enrolling
Updated:  9/21/2015
McLean Hospital
mi
from
Belmont, MA
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
Status: Enrolling
Updated: 9/21/2015
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
K & S Professional Research Services
mi
from
Little Rock, AR
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
K & S Professional Research Services
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Pharmacology Research Institute
mi
from
Newport Beach, CA
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
California Neuropsychopharmacology Clinical Research Inst.
mi
from
San Diego, CA
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
California Neuropsychopharmacology Clinical Research Inst.
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Pacific Research Network
mi
from
San Diego, CA
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Pacific Research Network
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Radiant Research, Inc.
mi
from
Denver, CO
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Comprehensive Psychiatric Care
mi
from
Norwich, CT
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Comprehensive Psychiatric Care
mi
from
Norwich, CT
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated:  9/23/2015
Compass Research LLC
mi
from
Orlando, FL
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients With Treatment Resistant Major Depression
Status: Enrolling
Updated: 9/23/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials